Document:

APPENDIX
A- Statement of Work

 

This
Statement of Work #1 (“SOW”), dated and effective May 18, 2020, submitted in connection with the Laboratory
Services Agreement by and between Cellular Technology Limited (“CTL”) and Generex Biotechnology Corporation, a public
company organized under the laws of Delaware , with its principal place of business located at 10102 USA Today Way, Miramar, FL
33025 (“Company”) (“Company”) dated May 15, 2020 (“Agreement”), is hereby agreed to by the
Parties.

Pursuant
to Article 2 of the Agreement, this SOW (including any attachments hereto) shall be governed by the terms and conditions of the
Agreement and, if applicable, any modifications to the Agreement agreed to by the Parties and set forth in this SOW under the
section below, entitled “Modifications to Agreement.” Any such modifications shall apply only to this SOW, and
not to any previous or subsequent SOWs, unless expressly stated otherwise in such other SOW.

	CTL	 	Company
	 	 	 
	/s/ Madalena Tarey-Lehmann	By:  	/s/ Joe Moscato
	Magdalena Tary-Lehmann, M.D., Ph.D.	Print Name:  	Joe Moscato
	Chief Scientific Officer	Title:  	President & Chief Executive Officer
	 	 	 

 

 

	non-GLP
study with no QA oversight - Pilot T cell ELISPOT project

Company
will:

		•	Use
                                         its own preferred carrier for shipments of materials to CTL.

		•	Provide
                                         thirty (30) peptides- test antigens (Ags).

		•	Provide
                                         up to thirty-nine (39) cryopreserved PBMC samples from different subjects with up to
                                         one time points.

CTL
will:

	Antigen preparation: CTL
will dissolve, pool, prepare and store working aliquots of the Company’s antigens for a fee. These synthesized antigens
are provided by the Company. Currently up to thirty (30) individual antigen preparations and one (1) peptide pool preparation
is assumed. Specifics on the antigens will be provided by the Company (e.g. sequence, purity, which Ags to be pooled etc.). In
the case that antigens are requested to be ordered by CTL, then CTL will be reimbursed by the Company (cost not included in the
work order).

 

	Optimization phase for ELISPOT:
CTL will optimize the antigen-specific triple color fluorescent IFN-gamma/ Granzyme B/ IL-5 ELISPOT assay for the testing
of human samples using the Company’s antigens of interest.

 

	Step 1: Screening-small titration
of the up to thirty-nine (39) cryopreserved positive responders PBMC in three Ag concentrations (e.g. 100 ug/ml, 25 ug/ml and
2.5 ug/ml) per provided antigen.

 

	The supernatant (SN) from IFN-gamma/Granzyme
B/IL-5 ELISPOT plate will be collected, frozen and stored until further instructions have been received by the Company.

 

	Step 2: Titration of the Ags in
the IFN-gamma/Granzyme B/IL-5 ELISPOT assay on up to four (4) antigen positive identified samples to define correct Ag concentration
to be used for each Ag.

 

	Step 3: Screening of thirty (30)
purchased sample(s) from CTL ePBMC® library with the thirty (30) antigens at one concentration, in the recall antigen
specific IFN-gamma/ Granzyme B/ IL-5 ELISPOT assay using one (1) sample per plate.

 

	Step 4: Titration of the one (1)
peptide pool in the IFN-gamma/Granzyme B/IL-5 ELISPOT assay on up to four (4) selected samples to define Ag concentration to be
used.

 

	Step 5: Final assay set up for
clinical sample testing- using selected four (4) positive samples and up to six (6) test antigens in the recall antigen specific
IFN-gamma/ Granzyme B/ IL-5 ELISPOT assay, whereby the test antigens are comprised of one (1) peptide pool and up to five (5)
individual peptides at one (1) concentration

 

		•	Human
                                         samples from CTL ePBMC® library used will contains approximately 1 x 107
                                         cells per vial.

 

	A CTL Development Report will
be generated once the Pilot study has been finalized.

 

		•	Additional
                                         optimization experiments (with input from Company before each experiment would be initiated)
                                         might be performed, however than an Amendment to this Work Order will need to be prepared.

 

		•	Results
                                         from each experiment will be forwarded to the Company. Results will be presented in the
                                         form of an Excel workbook, including among others, viability and recovery of cells, and
                                         mean and standard deviation of the spot counts, with a brief (1-2 pages) Internal Experimental
                                         Report that will summarize the results of the experiment performed.

 

	This phase of the study is a non
GLP study; however, if QA oversight would be requested by the Company, an additional 10% fee on all included activities (but not
supplies) would be incurred. If this option would be chosen, then CTL, Quality Assurance will inspect this non-regulated study,
which will include inspection of the raw data and final draft report. No QA Statement will be included in the final development
report, but records of inspection will be maintained with CTL QA.

 

		•	Overtime
                                         and weekend work will be billed as incurred for the ELISPOT assays.

 

		•	Short
                                         Term Storage: For the month in which the sample or antigen vial is received, storage
                                         is free. Thereafter a storage fee per vial will apply as incurred.

 

		•	Store
                                         the cryopreserved samples under liquid nitrogen vapor. CTL staff will enter specimen
                                         information into its sample management database in accordance with CTL standard operating
                                         procedures (SOPs). Long term storage of cryopreserved samples will incur a placement
                                         and a pulling fee per vial and a storage fee per vial per month as outlined in the attachment.

		•	Provide
                                         M.D./Ph.D. consultation at a rate of $250/hour.

 

		B.	General
                                         Provisions

 

		•	If
                                         Company later desires CTL to accelerate (rush) the schedule for any of the services to
                                         be rendered by CTL under the agreement or applicable work order, CTL will attempt to
                                         find a mutually agreeable modification of the schedule to accommodate Company’s
                                         request. However, CTL’s ability to meet such a request may depend upon the complexity
                                         of services involved, the volume of work requested, the availability of materials and/or
                                         personnel needed to meet the request, and the time frame involved. An acceleration of
                                         the specified dates outlined in the agreement or work order may result in accelerated
                                         services surcharges based upon the aforementioned factors.

 

		•	CTL
                                         Consumables: CTL has available multiple consumables for standardization of the assay
                                         performed at CTL. These include: vials of isolated and cryopreserved PBMC from a large
                                         batch (single time point), serum-free media (wash, test, and freezing media), peptides,
                                         control antigens, and protocols and training for the processing/cryopreservation of PBMC.
                                         All are available upon request and will be charged separately if incurred.

 

	CTL could offer the consultation
services of its staff for the support of the study and interpretation and management of the data. This includes biostatisticians,
PhD’s, technicians, etc.

 

		•	All
                                         records generated by CTL will be scanned. The Company will be given the option to request
                                         all materials to be shipped to a defined location or the records generated by CTL will
                                         be retained at CTL for two (2) years from the study completion date and signed final
                                         report. After two (2) years have elapsed, the Company will be contacted for further instructions
                                         and, if additional storage of records is requested, additional charges will be incurred.
                                         All records generated by CTL could be retained at CTL for two (2) years from the study
                                         completion date for no additional fee. Additional storage could be accommodated for a
                                         fee of $43.00 per inch binder per month.

 

		•	ELISPOT
                                         plates will be discarded after experimental data has been approved by the CTL Study Director/Responsible
                                         Scientist/ PI.

 

		•	Sample
                                         vials stored at CTL incur the storage fee per vial per month starting 1 month after their
                                         arrival. After completion of the study and the final report has been signed, samples,
                                         antigens and aliquots will be stored at CTL for up to four (4) weeks. CTL will send written
                                         instructions to the Company regarding onward shipping or disposal of the samples and
                                         aliquots stored at CTL. If onward shipping is requested or further storage by the Company,
                                         additional charges might occur.

 

	After two (2) years have elapsed,
CTL will make three (3) contacting attempts by mail or e-mail. If the Company will not respond to CTL within 30 days of the third
attempt, then this will automatically authorize CTL to discard the remaining study records, materials and samples pertaining to
this study.

 

		C.	Payment
                                         Terms

 

In
consideration of the Services performed by CTL, Company hereby agrees to pay CTL in accordance with the payment terms and schedules
set forth below as outlined and in budget attachment:

 

Part
A: non-GLP study with no QA oversight - Pilot T cell ELISPOT project

0.5%
of the costings ($4,697.39 USD) are due once work order has been signed. Cost for this part is $939,478.00USD.

Note:
All deposits are non-refundable, and will be used against work performed.

 

The
balance of the costings will be invoiced on a monthly basis for activities completed the prior month.

 

CTL
will invoice Company only for actual services performed and materials provided; (see Attachment), incorporated herein by reference,
for itemized pricing. Company will pay CTL’s invoices within 30 (thirty) days of receipt. Upon the expiration of thirty
(30) days from the date of the invoices, unpaid balances shall bear interest at the rate of one and one-half percent (1 1⁄2%)
per month. Invoices shall be calculated and payments due in U.S. Dollars. If Company has specific invoicing instructions or requirements,
e.g. the issue of a purchase order or billing to a separate address, please advise. In the event costs exceed the estimated total
amount for each project by ten (10) percent or more. CTL shall seek written approval from Company. Additional storage will be
accommodated for a fee of $43.00 per inch binder per month. Company will be contacted for further instructions and, if additional
storage of records is requested, additional charges will be incurred.

 

All
original invoices shall be sent to: ________________________________________

Invoices
must reference: __________________________________________________

 

Payments
to CTL should be made to:If wiring payment, the wiring Instructions are:

Cellular
Technology Limited (CTL), Beneficiary: Cellular Technology Limited.

Attn:
Accounting DepartmentBank: PNC Bank

20521
Chagrin Boulevard,Account Number: 4228503614

Shaker
Heights,Routing Number: 041000124

OH
44122, USA(Domestic Wires: Centralized Columbus, Ohio)

Email:Swift
Code: PNCCUS33

CROBilling@immunospot.com(International
Wire Transfers only)

Tax
ID number: 34-1870041

 

This
Work Order will remain in effect until the Services have been performed, unless earlier terminated as provided in the Agreement.

    	 

    	 

    

 

Attachment
1

 

non-GLP
study with no QA oversight - Pilot T cell ELISPOT projectEX-10.1

 Exhibit 10.1 

June 5, 2020 
 To the Borrowers (as defined

 in Exhibit D hereto) 
 333 South Grand Avenue, 28th
Floor 
 Los Angeles, CA 90071 
 Uncommitted
Unsecured Line of Credit 
 Ladies and Gentlemen: 

Oaktree Fund GP I, L.P. (the “Lender”) is pleased to offer to the Persons listed in Exhibit D hereto (as the same may
be updated from time to time) an uncommitted unsecured line of credit up to a maximum amount of $125,000,000 (the “Line”) under which the Lender may, from time to time in its sole discretion, approve requests by one or more
Borrowers for Loans. Unless the context otherwise requires, capitalized terms used in this Agreement shall have the meanings given thereto in Exhibit C hereto. 

This Agreement and the arrangement described herein do not constitute a commitment by the Lender to extend any credit or to make any financial
accommodation to any Borrower, and any decision to extend credit or make any financial accommodation under the Line shall be made by the Lender in its sole discretion. Any extension of credit or financial accommodation that the Lender may make under
the Line will be on such terms and conditions as the Lender may require at the time a Borrower requests such extension of credit or financial accommodation and must be evidenced by documents in form and substance satisfactory to the Lender. Each
request for a Loan will be considered individually in light of considerations that the Lender, in its sole discretion, may then find pertinent, including any credit exposure which the Lender may have to the Borrowers in connection with the Line and
any other transactions with the Borrowers. 
 Section 1.    Purpose. Requests for Loans
under the Line may be made from the date hereof to but excluding June 30, 2021 (the “Stated Expiration Date”), as such date may be extended pursuant to Section 11 hereof. Subject to the terms and conditions of the Master
Note, Loans shall be used by the applicable Borrower to provide financing for Investments, to repay debt or pay other obligations, to manage working capital requirements and for other purposes permitted by such Borrower’s Constituent Documents.

 Section 2.    Requesting and Evidencing Loans. (a) In order to request a Loan,
a Borrower or Borrowers shall deliver to the Lender a request substantially in the form of Exhibit A hereto or such other form satisfactory to the Lender (a “Loan Request”), which request may be delivered or furnished by
electronic communication. Such Borrower(s) shall use commercially reasonably efforts to deliver a completed Loan Request to the Lender no later than 1:00 p.m., New York City time, on the date of the borrowing. The failure of any Borrower to comply
with such time period shall not constitute a default under this Agreement. 
 (b)    Upon the date of execution and
delivery of this Agreement, an authorized person of each Borrower party hereto shall execute and deliver to the Lender the Master Note on behalf of such Borrower. Schedule II of the Master Note shall be updated from time to time to reflect
changes in the composition of Borrowers after the date hereof. Any and all Loans made to a Borrower shall be evidenced by the Master Note. 

 Section 3.    [Reserved.] 

Section 4.    Representations and Warranties. Each Borrower hereby represents and
warrants to the Lender that (a) it has been duly formed and is validly existing in its jurisdiction of organization; (b) each of the Loan Documents to which it is a party has been duly authorized, executed, and delivered by it and
constitutes its legal, valid, and binding obligation, enforceable against it in accordance with the terms thereof, subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws
relating to or affecting creditors’ rights generally, (ii) general equitable principles (whether considered in a proceeding in equity or at law), (iii) an implied covenant of good faith and fair dealing, and (iv) the effects of the
possible judicial application of foreign laws or foreign governmental or judicial action affecting creditors rights; (c) its execution, delivery, and performance of this Agreement and the other Loan Documents to be delivered by it have been
duly authorized by all requisite action and will not conflict with, violate, result in any default under, or result in the creation of any Lien (as defined in the Master Note) on any of its assets pursuant to its Constituent Documents, any
applicable law or regulation, any judgment, order, or decree binding on it or any material agreement or instrument or contractual restriction to which it is party or which is binding on it or its properties; (d) the proceeds of any Loan shall
be to provide financing for Investments, to repay debt or pay other obligations, to manage working capital requirements and for other purposes permitted by the applicable Borrower’s Constituent Documents; and (e) it is not an
“investment company” as defined in, or subject to regulation under, the Investment Company Act of 1940, as amended. 

Section 5.    Expenses; Indemnity. (a) Each Borrower shall pay all reasonable and
documented costs and expenses (including, without limitation, all reasonable and documented legal fees) incurred in connection with the preparation, execution, delivery and administration of this Agreement and the other Loan Documents. 

(b)    Each Borrower agrees to indemnify the Lender, its directors, officers, employees and agents (each such Person, an
“Indemnitee”) against, and to hold each Indemnitee harmless from, its proportionate share of any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel fees, charges and disbursements,
incurred by or asserted against any Indemnitee arising out of (i) the execution or delivery of this Agreement or any other Loan Document or any agreement or instrument contemplated thereby, the performance by the parties thereto (other than the
Lender) of their respective obligations thereunder or the consummation of the transactions contemplated thereby, (ii) the use of the proceeds of any of the Loans, or (iii) any claim, litigation, investigation, or proceeding relating to any
of the foregoing, whether or not any Indemnitee is a party thereto, in each case, to the fullest extent possible without such indemnification being inconsistent with such Borrower’s Constituent Documents. The liability of each Borrower under
this Section 5 shall be determined in accordance with Section 8(n) of this Agreement. 
 (c)    The provisions
of this Section 5 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of all or any portion of the Loans, the
invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Lender. Upon Borrowers’ receipt of written demand therefor, all amounts due under this
Section 5 shall be payable in accordance with Section 12. 
 Section 6.    WAIVER
OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE OTHER
LOAN DOCUMENTS, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT, OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT, OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE
MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

  
 2 

 Section 7.    Survival. All covenants,
agreements, representations, and warranties made by the Borrowers herein and in the certificates or other instruments delivered in connection with or pursuant to this Agreement shall be considered to have been relied upon by the Lender and shall
survive the execution and delivery of this Agreement and the making of any Loan, regardless of any investigation made by the Lender or on its behalf and notwithstanding that the Lender may have had notice or knowledge of any default under any Loan
Document or incorrect representation or warranty at the time any Loan is extended under the Line, and shall continue in full force and effect as long as any Loan remains outstanding and any amount remains due but unpaid under any Loan Document after
the Line has expired or terminated. 
 Section 8.    Miscellaneous. (a) Each
Borrower acknowledges and agrees that no provision of this Agreement or any other Loan Document referred to herein, and no course of dealing by the Lender in connection herewith, shall be deemed to create or impose, by implication or otherwise, any
commitment or obligation on the part of the Lender to make Loans. Accordingly, each Borrower agrees that any Loan shall be made solely at the Lender’s discretion. 

(b)    Neither this Agreement nor any other Loan Document, nor any provision hereof or thereof, may be waived, amended, or
modified except pursuant to an agreement or agreements in writing entered into by the Borrowers party thereto and the Lender. No failure or delay by the Lender in exercising any right or power under this Agreement or any other Loan Document shall
operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any
other right or power. All rights and remedies afforded to the Lender by reason of this Agreement and the other Loan Documents are separate and cumulative remedies, and shall be in addition to all other rights and remedies in favor of the Lender
existing at law or in equity or otherwise. None of such remedies, whether or not exercised by the Lender, shall be deemed to exclude, limit or prejudice the exercise of any other legal or equitable remedy or remedies available to the Lender. No
waiver of any provision of any Loan Document or consent to any departure by any Borrower therefrom shall in any event be effective unless the same shall be permitted by the first sentence of this Section 8(b), and then such waiver or consent
shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of any Loan shall not be construed as a waiver of any default, regardless of whether the Lender may
have had notice or knowledge of such default at the time. 
 (c)    THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS SHALL BE
CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. 
 (d)    Each Borrower hereby
irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court for the Southern District of New
York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or any other Loan Document, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably
and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final
judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement shall affect any right that the Lender may otherwise
have to bring any action or proceeding relating to this Agreement against any Borrower or its properties in the courts of any jurisdiction. 

  
 3 

 (e)    Each Borrower hereby irrevocably and unconditionally waives, to
the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Loan Document in any court
referred to in Section 8(d). Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. 

(f)    Each Borrower hereby agrees to the service of process in any legal action or proceeding with respect to this
Agreement or any other Loan Document may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage paid, to such Borrower at 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071,
but the failure of such Borrower to receive such copy shall not affect in any way the service of such process. 

(g)    The provisions of this Agreement and the other Loan Documents shall be binding upon and inure to the benefit of the
parties hereto and thereto and their respective successors and assigns permitted hereby, except that (i) none of the Borrowers may assign or otherwise transfer any of its rights or obligations hereunder or under any other Loan Document without
the prior written consent of the Lender (and any attempted assignment or transfer by any Borrower without such consent shall be null and void) and (ii) the Lender may not assign or otherwise transfer its rights or obligations hereunder or under
any other Loan Document without the prior written consent of the Borrowers (such consent not to be unreasonably withheld, delayed or conditioned); provided, however, the consent of the applicable Borrower(s) shall not be required upon
the occurrence and during the continuance of an Event of Default (as defined in the Master Note) set forth in clauses (b), (e) or (f) of such definition. Nothing in this Agreement, expressed or implied, shall be construed to confer upon any
Person (other than the parties hereto, the Indemnitees, and their respective successors and assigns permitted hereby) any legal or equitable right, remedy or claim under or by reason of this Agreement or any other Loan Document. 

(h)    Each Borrower hereby acknowledges that: (i) the Lender has no fiduciary relationship with or fiduciary duty to
any Borrower arising out of or in connection with this Agreement or any other Loan Document, and the relationship between the Lender, on the one hand, and the Borrowers, on the other hand, in connection herewith or therewith is solely that of
creditor and debtor; and (ii) no joint venture is created hereby or by any other Loan Document or otherwise exists by virtue of the transactions contemplated hereby between any Borrower and the Lender. 

(i)    Any provision of any Loan Document held to be invalid, illegal or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions thereof; and the invalidity of a particular provision in a
particular jurisdiction shall not invalidate such provision in any other jurisdiction. 
 (j)    In accordance with the
requirements of Title III of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Act”), the Lender hereby notifies each Borrower that pursuant to
the requirements of the Act, it is required to obtain, verify and record information that identifies such Borrower, which information includes the name and address of such Borrower and, subject to applicable confidentiality requirements (as
determined by such Borrower), other information that will allow the Lender to identify such Borrower in accordance with the Act. 

  
 4 

 (k)    The definitions of terms herein shall apply equally to the
singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine, and neuter forms. The words “include”, “includes” and “including” shall
be deemed to be followed by the phrase “without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. Unless the context requires otherwise (i) any definition of
or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented, or otherwise modified (subject to any restrictions on such
amendments, supplements, or modifications set forth herein), (ii) any reference herein to any Person shall be construed to include such Person’s successors and assigns, (iii) the words “herein”, “hereof” and
“hereunder”, and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (iv) all references herein to Sections, Exhibits and Schedules shall be construed to
refer to Sections of, and Exhibits and Schedules to, this Agreement, (v) the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and
properties, including cash, securities, accounts, and contract rights, and (vi) all references herein to the term “law” shall be construed to include statutes and any rules, regulations or orders thereunder. 

(l)    This Agreement and the other Loan Documents may be executed in any number of counterparts, each of which shall be
deemed an original, and all of which taken together shall constitute but one agreement. Delivery of an executed signature page of this Agreement or the other Loan Documents by any electronic means that reproduces an image of the actual executed
signature page shall be as effective as delivery of a manually executed counterpart of this Agreement or the other Loan Documents. 

(m)    This Agreement and the other Loan Documents constitute the entire contract among the parties relating to the subject
matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. 

(n)    Notwithstanding anything herein or in any other Loan Document to the contrary, the liability of the Borrowers under
this Agreement and the other Loan Documents with respect to any Obligations attributable to one or more Loans shall be several (but not joint). The liability of the Borrowers under this Agreement and the other Loan Documents with respect to any
Obligations that relate to the Loan Documents or the Line generally, and are not attributable to any particular Loans, shall also be several (but not joint). For the avoidance of doubt, the occurrence of a Default (as defined in the Master Note) or
an Event of Default with respect to one Borrower shall not, by itself, result in a Default or an Event of Default with respect to any other Borrower. 

Section 9.    Termination Rights. Each Borrower shall have the right to terminate this
Agreement and the other Loan Documents in respect of itself, at any time, upon written notice to the Lender and payment in full of any and all outstanding Obligations of such Borrower. The Lender shall have the right to terminate this Agreement and
the other Loan Documents with respect to any or all Borrowers at any time upon delivery of written notice to such Borrower(s). For the avoidance of doubt, the Lender shall not be required to fund new loans once notice has been provided of its intent
to terminate this Agreement. 
 Section 10.    Limited Recourse. Notwithstanding
anything to the contrary contained in this Agreement or under provisions of applicable law, none of the Lender and its assignees shall have any recourse to any Investor or any of their respective assets for any indebtedness or other monetary
obligation incurred under the Loan Documents; provided, however, that nothing contained herein (a) shall constitute a waiver or release of the Borrowers of any indebtedness or other monetary obligation evidenced by this Agreement
or the Master Note or (b) shall limit or otherwise restrict recourse to and enforcement against the applicable Borrower itself. 

  
 5 

 Section 11.    Extension. Provided
(a) the Borrowers shall have delivered to the Lender an extension request not less than thirty (30) days prior to the initial Stated Expiration Date, (b) there exists no Event of Default, and (c) the Lender shall have provided
its consent, such consent to be given in its sole and absolute discretion, the Borrowers shall have the option to extend the Stated Expiration Date for additional terms of no longer than twelve (12) months each. 

Section 12.    Demand Obligation. The Loans, together with all accrued and unpaid
interest thereon, are payable on the earliest of (i) the date Lender demands payment hereunder, (ii) the Stated Expiration Date and (iii) the occurrence of a Change of Control; provided, that the applicable Borrower(s)
shall have 180 days (in the case of clauses (i) and (ii)) or 45 days (in the case of clause (iii)) to make such payment as provided for in this Section 12. Accordingly, the Lender can demand payment in full of the Loans at any time in its
sole discretion even if the Borrowers have complied with all of the terms of this Agreement and the other Loan Documents. Upon the earlier of written demand for payment by the Lender in connection with the Obligations of any Borrower and the Stated
Expiration Date, to the extent that its Obligations have not otherwise been satisfied, such Borrower shall, promptly following receipt of net cash proceeds from the acceptance of subscriptions from any Investors and any sale or other disposition of
any asset, apply such proceeds to the repayment in full of the Loans and the Obligations. For the avoidance of doubt, no Borrower shall be required to use any such net cash proceeds that are (a) required to be distributed by such Borrower in
order for it to maintain its REIT status or avoid any entity level tax as determined by such Borrower in its sole discretion, (b) required to meet any repurchase requests up to the maximum repurchase levels of 2% of Borrowers’ net asset
value per calendar month and 5% per fiscal quarter, (c) necessary for such Borrower to close on any acquisition such Borrower entered into prior to Lender’s demand for payment, and (d) necessary for such Borrower to distribute to
Investors an amount consistent with the actual per share distributions made by such Borrower to its Investors in the immediately preceding fiscal quarter. 

[SIGNATURE PAGES FOLLOW] 

  
 6 

 
			
	Sincerely yours,
	
	OAKTREE FUND GP I, L.P.
		
	By:	 	/s/ Dan Levin
	Name:	 	Dan Levin
	Title:	 	Authorized Signatory
		
	By:	 	/s/ Jordan Mikes
	Name:	 	Jordan Mikes
	Title:	 	Authorized Signatory

 AGREED AND ACCEPTED AS OF 

THE DATE FIRST ABOVE WRITTEN: 
  

			
		
	By:	 	/s/ Manish Desai
		 	Manish Desai, for each of the Borrowers listed on Schedule II of the Master Note

 [Signature page to Uncommitted Unsecured Line of Credit Agreement] 

 EXHIBIT A TO LETTER AGREEMENT 

[Form of Loan Request] 

OAKTREE REAL ESTATE INCOME TRUST, INC. 

Funding Request Form 
  

			
	 Project Name(s)
	  	 
		  	
	 Borrower
	  	 
		  	
	 Currency / Interest Period
	  	 
		  	
	 Amount needed
	  	 
		  	
	 Date required
	  	 
		  	
	 Bank Account Details
	  	 
	
	
	
	
	

 Kindly send swift confirmation on value date to confirm receipt of funds by
                         

  
 A-1 

 EXHIBIT B TO LETTER AGREEMENT 

[Form of Master Note] 

PROMISSORY NOTE 
 [DATE]

 New York, New York 
 FOR VALUE
RECEIVED, each of the entities listed on Schedule II hereto (as updated from time to time, collectively, the “Borrowers”; each, a “Borrower”), hereby promises to pay to the order of Oaktree Fund GP I, L.P.
(the “Lender”), at the Lender’s office at 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, the aggregate unpaid principal amount of each loan made by the Lender to such Borrower (each a “Loan”;
collectively, the “Loans”) on the due date for each Loan (as recorded by the Lender on its books and records and/or on Schedule I hereto or continuation thereof). 

Loans evidenced hereby are made pursuant to that certain letter agreement dated June 5, 2020 between the Lender and the Borrowers party
thereto (as amended, supplemented, or otherwise modified from time to time, the “Letter Agreement”) providing for an uncommitted unsecured line of credit. This Note is the “Master Note” as defined in the Letter Agreement.
The liability of each Borrower under this Note shall be governed by the terms of Section 8(n) of the Letter Agreement. The recourse to any Investor under this Note shall be limited as provided in Section 10 of the Letter Agreement. 

Section 1.    Defined Terms. Unless otherwise defined herein, capitalized terms herein
shall have the meanings assigned to them in the Letter Agreement. As used herein, the following terms shall have the meanings specified below: 

“Code” means the Internal Revenue Code of 1986, as amended from time to time, and any successor statute or statutes. 

“Default” means any event or condition which, with the passage of time, the giving of notice, or both, would give rise to an
Event of Default. 
 “Dollars” or “$” mean, at any time, the lawful currency of the United States
of America. 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time, and any
successor statute or statutes. 
 “ERISA Investor” means an Investor in the applicable Borrower that is (a) an
“employee benefit plan” (as such term is defined in Section 3(3) of ERISA) or trust or custody account therefor (or a master trust or custody account therefor) subject to Title I of ERISA, (b) a group trust, as described in
Revenue Ruling 81-100 or insurance company separate account that includes one or more Persons described in clause (a) above, or (c) a partnership, insurance company general account, or other account
or other fund that is deemed to hold “plan assets” pursuant to the Plan Asset Regulation of one or more Persons described in clause (a) or (b) above. 

“Event of Default” has the meaning set forth in Section 7 of this Note.

  
 B-1 

 “Excluded Taxes” means (a) any income or franchise Taxes imposed as a
result of a present or former connection between the Lender and the jurisdiction of the governmental authority imposing such Tax or any political subdivision or taxing authority thereof or therein (other than any such connection arising on account
of the execution, delivery, performance, filing, recording, or enforcement of, or other activities contemplated in, this Note), (b) any branch profits Taxes imposed by the United States of America or any similar Tax imposed by any other jurisdiction
in which the Lender is located, (c) any withholding Taxes resulting from any law in effect on the date hereof (or on the date the Lender designates a new lending office or on the date the Lender assigns this Note to another party), except to
the extent that Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from a Borrower with respect to such withholding Taxes pursuant to the paragraphs
relating to payments made without deduction for Indemnified Taxes, to exemption from or reduction of withholding Tax and to refund of Indemnified Taxes, (d) any Taxes attributable to the Lender’s failure to comply with the paragraphs in
Section 4 relating to exemptions from or reduction of withholding Taxes (including with respect to FATCA), and (e) any withholding Taxes imposed under FATCA. 

“FATCA” means Sections 1471 through 1474 of the Code as in effect on the date hereof (or any amended or successor version
that is substantively comparable and not materially more onerous to comply with), any current or future regulations promulgated thereunder or official interpretations thereof, any agreements entered into pursuant to Section 1471(b) of the Code
(or any amended or successor version described above), and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among governmental authorities and implementing the
foregoing. 
 “Indemnified Taxes” means Taxes, other than Excluded Taxes, imposed on or with respect to payments under this
Note. 
 “Interest Payment Date” means (i) the last day of the Interest Period; and (ii) the date of any payment
of principal. 
 “Interest Period” means, with respect to a Loan, the period commencing on the date such Loan is made and
ending on the numerically corresponding day one week, two weeks, one calendar month, two calendar months, three calendar months, six calendar months or nine calendar months thereafter, as selected by the applicable Borrower and as recorded by the
Lender on its books and records and/or Schedule I hereto or any continuation thereof, or if such day is not a Business Day, then on the immediately succeeding Business Day; provided, that if such Business Day would fall in the next
calendar month, such Interest Period shall end on the immediately preceding Business Day; and provided, further, that any Interest Period which commences on the last Business Day of a calendar month (or on any day for which there is no
numerically corresponding day in the appropriate subsequent calendar month(s)) shall, subject to the foregoing proviso, end on the last Business Day of the appropriate calendar month. 

“Libor Rate” means, for any Interest Period for each Loan comprising part of the same borrowing, the rate per annum as
published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be reasonably designated by the Lender from time to time) at approximately 11:00 a.m., London time, two (2) Business
Days prior to the first day of the Interest Period for such Loan as the rate for deposits in Dollars with a maturity comparable to such Interest Period. 

“Lien” means, (a) with respect to any asset, (x) any mortgage, deed of trust, lien, pledge, encumbrance, charge or
security interest in or on such asset and (y) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement relating to such asset, and (b) in the case of securities, any purchase
option, call or similar right of a third party with respect to such securities. 

  
 B-2 

 “Plan Asset Regulations” means U.S. Department of Labor Regulation Section 2510.3-101, 29 C.F.R. § 2510.3-101, as modified by Section 3(42) of ERISA, and any successor statutory or regulatory provisions. 

“Taxes” means any present or future taxes, levies, imposts, duties, deductions, charges, or withholdings (including backup
withholding), assessments or fees imposed by any governmental authority, including any interest, additions to tax or penalties applicable thereto. 

Section 2.    Interest. Interest shall accrue on the unpaid balance of the principal
amount of each Loan (including PIK Interest) made to a Borrower from and including the date of such Loan to but excluding the date of its repayment at a fixed rate per annum equal to such Borrower’s then-current borrowing rate offered by a
third-party provider or, if such rate is not offered, the Libor Rate applicable to such Loan plus 2.25%. Interest shall be calculated on the basis of a year of 360 days for the actual number of days elapsed. All accrued and unpaid interest
(including any accrued PIK Interest) as of an applicable Interest Payment Date shall be paid in kind by capitalizing such interest and adding it to the principal amount outstanding under this Note (“PIK Interest”). In the event that
any principal of or interest accrued and unpaid hereon shall not be paid when due, interest shall be payable on any such overdue amount upon written demand at a rate per annum equal to 2.0% in excess of the interest rate specified in the immediately
preceding sentence (but not at a rate higher than the highest interest rate permitted by applicable law) on any overdue principal and, to the extent permitted by applicable law, on any overdue interest, from the due date thereof to the date of
actual payment (after as well as before judgment and during bankruptcy). All payments hereunder shall be made in Dollars and in immediately available funds and in accordance with the last paragraph of Section 8. Notwithstanding any other
provision hereof, if the Lender shall determine prior to the commencement of any Interest Period that adequate and reasonable means do not exist for ascertaining the Libor Rate, then the Lender shall promptly give notice thereof to the Borrowers and
at the Lender’s option it may demand repayment of the affected Loan(s), and even absent such demand, no Loan shall be created or continued for such Interest Period until adequate and reasonable means exist for ascertaining the Libor Rate or a
successor thereto. 
 Section 3.    Prepayment; Repayment. Each Borrower shall have the
right voluntarily to prepay without penalty or premium, at any time and from time to time, all or any portion of the outstanding principal balance of any Loan to it; provided, that accrued interest upon the amount prepaid shall be paid at the
time of any such prepayment; provided, further, that if any principal of a Loan is paid prior to the last day of the Interest Period therefor set forth in the books and records of the Lender and/or Schedule I hereto or any
continuation thereof (whether by acceleration, prepayment or otherwise), such Borrower also agrees to pay to the Lender such amount as is reasonably determined by the Lender to represent the aggregate losses, costs, and expenses incurred or suffered
by the Lender as a result of such prepayment. A certificate of the Lender setting forth the foregoing amount shall, absent manifest error, be conclusive and binding for all purposes. The applicable Borrower shall pay the Lender the amount shown as
due on any such certificate promptly upon receipt thereof. 
 Each Loan shall be paid in full by the applicable Borrower, together with all accrued and
unpaid interest thereon, in accordance with Section 12 of the Letter Agreement. 

Section 4.    Taxes. Any and all payments by or on account of a Borrower under this Note
shall be made free and clear of and without deduction for any Taxes, except as required by applicable law. If a Borrower shall be required by law to withhold or deduct any Taxes from such payments, then (i) such Borrower shall make such
withholdings or deductions, (ii) such Borrower shall pay the full amount withheld or deducted to the relevant taxing authority in accordance with applicable law, and (iii) if the Tax in question is an Indemnified Tax, the sum payable by
the Borrower to the Lender shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section 4), the Lender receives an amount equal to the sum it would
have received had no such deductions been made. The applicable Borrower shall indemnify the Lender for the full amount of any Indemnified Taxes payable or paid by the Lender. 

  
 B-3 

 To the extent the Lender is entitled to an exemption from or a reduction of withholding Tax
with respect to payments made by or on account of a Borrower, the Lender shall deliver to such Borrower, at the time or times reasonably requested by such Borrower, such properly completed and executed documentation prescribed by applicable law as
will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, the Lender, if requested by such Borrower, shall deliver such other documentation prescribed by applicable law or reasonably requested by
such Borrower as will enable such Borrower to determine whether or not the Lender is subject to backup withholding or information reporting requirements. The Lender agrees that if any form or certification it previously delivered expires or becomes
obsolete or inaccurate in any respect, it shall, upon the reasonable request from such Borrower, update such form or certification or promptly notify such Borrower in writing of its legal inability to do so. 

If a payment made to the Lender under this Note would be subject to U.S. federal withholding tax imposed by FATCA if the Lender were to fail
to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), the Lender shall deliver to the relevant Borrower at the time or times prescribed by law and at
such time or times reasonably requested by a Borrower such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by a Borrower or as
may be necessary for such Borrower to comply with their obligations under FATCA, to determine whether the Lender has or has not complied with such Lender’s obligations under FATCA and, if necessary, to determine the amount to deduct and
withhold from such payment. Solely for purposes of this clause, “FATCA” shall include any amendments made to FATCA after the date hereof. 

If the Lender receives a refund in respect of any Indemnified Taxes as to which it has been indemnified by a Borrower or with respect to which
a Borrower has paid additional amounts pursuant to this Section 4, it shall pay over such refund to the applicable Borrower (but only to the extent of indemnity payments made, or additional amounts paid, by such Borrower pursuant to this
Section 4), net of all out-of-pocket expenses of the Lender and without interest (other than any interest paid by the relevant governmental authority with respect
to such refund); provided, that such Borrower, upon the request of the Lender, agrees to repay the amount paid over to such Borrower (plus any penalties, interest or other charges imposed by the relevant governmental authority) to the Lender
in the event the Lender is required to repay such refund to such governmental authority. 
 Each Borrower shall maintain at one of its
offices a copy of each assignment delivered to it and a register for the recordation of the names and addresses of the Lender (and any permitted assignee lender (each, an “Assignee”)), and principal amount (and stated interest) of
the amounts owing to the Lender and each Assignee, as applicable, pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive absent manifest error, and the applicable Borrower,
the Lender and the Assignee(s) (if any) shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as the Lender or an Assignee, as the case may be, hereunder for all purposes of this Note, notwithstanding notice to
the contrary. No transfer is effective until the transferee is reflected as such on the Register pursuant to this Section 4. The parties intend for the Loan to be in registered form for tax purposes and to the extent of any conflict with this
Section 4, this Section 4 shall be construed in accordance with that intent. 

  
 B-4 

 Section 5.
    Covenants. At any and all times as the principal of or interest on any Loan evidenced hereby remains unpaid, each Borrower agrees that it will: 

(a)    [reserved]; 

(b)    not amend or modify, or permit any amendment or modification of, its Constituent Documents in a manner that could
reasonably be expected to materially and adversely affect the Lender; and 
 (c)    if at any time amounts in respect of
unpaid principal or interest for any Loan to it evidenced by this Note become due and payable, make such payments in accordance with the last paragraph of Section 8. 

Section 6.     Representations and Warranties. Each Borrower,
with respect to itself, represents and warrants on the date hereof and       on each date that a Loan shall be made that (a) it has been duly formed and is validly existing; (b) it has provided the Lender with
a true and complete copy of its Constituent Documents as in effect on the date hereof; (c) this Note has been duly authorized, executed, and delivered by such Borrower and constitutes its legal, valid, and binding obligation, enforceable in
accordance with its terms, subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, (ii) general equitable
principles (whether considered in a proceeding in equity or at law), (iii) an implied covenant of good faith and fair dealing, and (iv) the effects of the possible judicial application of foreign laws or foreign governmental or judicial action
affecting creditors rights; (d) its execution, delivery, and performance of this Note have been duly authorized by all requisite action and will not conflict with, violate, result in any default under, or result in the creation of any Lien on
any of its assets pursuant to, its Constituent Documents, any applicable law or regulation, any judgment, order or decree binding on it or any material agreement or instrument or contractual restriction to which it is party or which is binding on it
or its properties; (e) [reserved]; (f) [reserved]; and (g) assuming that no portion of the assets used by the Lender in connection with the Loans hereunder constitutes assets of (A) an “employee benefit plan” (as such term is
defined in Section 3(3) of ERISA) or “plan” (as such term is defined in Section 4975(e) of the Code) or trust or custody account therefor (or master trust or custody account therefor) subject to Title I of ERISA or
Section 4975 of the Code, (B) a group trust, as described in Revenue Ruling 81-100 or insurance company separate account that includes one or more Persons described in clause (A) above, or
(C) a partnership, insurance company general account, or other account or other fund that is deemed to hold “plan assets” pursuant to the Plan Asset Regulation of one or more Persons described in clause (A) or (B) above, then the
transactions contemplated by this Note will not constitute a nonexempt prohibited transaction (as such term is defined in Section 4975(c)(1)(A)-(C) of the Code or Section 406(a) of ERISA) that could subject the Lender to any tax or penalty
on prohibited transactions imposed under Section 4975 of the Code or Section 502(i) of ERISA.  

Section 7.     Events of Default. Any of the following shall, with
respect to a Borrower, constitute an “Event of Default”: 
 (a)    any representation or warranty by such
Borrower hereunder proves to be untrue or incorrect in any material respect when made; 
 (b)    any principal or
interest, regardless of amount, due with respect to such Borrower under this Note is not paid, with respect to principal, on the date when and as the same shall become due and payable, whether upon maturity, acceleration, demand (subject to the last
paragraph of Section 8) or otherwise and, with respect to interest, within five (5) Business Days after the date when and as the same shall become due and payable; 

(c)    [reserved]; 

(d)    such Borrower shall fail to observe or perform any other term, covenant, condition or agreement contained herein and
such failure shall continue for thirty (30) days after notice from the Lender; 

  
 B-5 

 (e)    an involuntary proceeding shall be commenced or an involuntary
petition shall be filed against such Borrower seeking (i) liquidation, reorganization or other relief in respect of such Borrower, or its debts, or of a substantial part of its assets, under any Federal, state or foreign bankruptcy, insolvency,
receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for such Borrower, and, in any such case, such proceeding or petition shall continue
undismissed for sixty (60) days or an order or decree approving or ordering any of the foregoing shall be entered; 

(f)    such Borrower shall (i) voluntarily commence any proceeding or file any petition seeking liquidation,
reorganization or other relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any
proceeding or petition described in clause (e) above, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for such Borrower for a substantial part of its assets,
(iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the
foregoing; 
 (g)    such Borrower shall become unable, admit in writing its inability or fail generally to pay its
debts as they become due; or 
 (h)    one or more judgments for the payment of money in an aggregate amount in excess
of $25,000,000 shall be rendered against such Borrower and the same shall not be covered by insurance and remain undischarged for a period of thirty (30) consecutive days during which execution shall not be effectively stayed, or any action
shall be legally taken by a judgment creditor to attach or levy upon any assets of any or any affiliate of them to enforce any such judgment; or 

(i)    beginning with the first day of the taxable year in which such Borrower qualifies as a REIT under Section 856
of the Code, the date on which such Borrower no longer qualifies as a REIT under Section 856 of the Code. 
 For the avoidance of
doubt, the occurrence of a Default or an Event of Default with respect to one Borrower shall not, by itself, result in a Default or an Event of Default with respect to any other Borrower. If any Event of Default occurs and is continuing, the Lender
may declare the entire outstanding principal amount of each Loan to the applicable Borrower and all accrued and unpaid interest owing thereon to be immediately due and payable by such Borrower; provided that if an Event of Default described in
Sections 7(b), 7(e) or 7(f) has occurred and is continuing, the outstanding principal amount of each Loan to such Borrower and all accrued and unpaid interest owing thereon shall become immediately due and payable concurrently therewith, without any
further action by the Lender, and without presentment, demand, protest, notice of default, notice of acceleration, or of intention to accelerate or other notice of any kind, all of which each of the Borrowers hereby expressly waives.

  
 B-6 

 
Section 8.     Miscellaneous. 
 Each
Borrower hereby waives diligence, presentment, demand, protest and notice of any kind whatsoever. Neither the failure nor any delay on the part of the Lender in any particular instance to exercise any right, power or privilege hereunder shall
constitute a waiver thereof in that or any subsequent instance. No consent or waiver of the terms of this promissory note (this “Note”) shall be effective unless in writing. All rights and remedies of the Lender are cumulative and
concurrent, and no single or partial exercise by the Lender of any right, power or privilege shall preclude any other or further exercise of any other right, power or privilege. 

Except as may be required by law, all payments to be made hereunder by the applicable Borrower shall be made without set-off or counterclaim, in immediately available funds and in Dollars at and for the account of the Lender. 

Each Loan evidenced by this Note and all payments and prepayments of the principal thereof and any outstanding balance and interest thereon
and the respective dates thereof shall be recorded by the Lender in its books and records (which may be electronic in nature) and at any time and from time to time may be, and shall be prior to any transfer and delivery of this Note, entered by the
Lender on Schedule I attached hereto or any continuation thereto, and recorded in the Register in accordance with Section 4. The failure by the Lender to make any such entries or notations on such schedule or in its internal records or
any error in such a notation shall not affect the obligations of the applicable Borrower under this Note. 
 In addition to the other sums
payable hereunder, upon receipt of written demand therefor, each Borrower agrees to pay to the Lender all costs and expenses (including reasonable attorneys’ fees) which may be incurred in connection with the enforcement of such Borrower’s
obligations hereunder. 
 All notices or other communications provided for hereunder shall be in writing (including telecommunications) and
shall be mailed, facsimiled or delivered, if to a Borrower, at the address of such Borrower set forth underneath such Borrower’s signature, if to the Lender, at Oaktree Fund GP I, L.P., 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071,
Attention: Jordan Mikes, or in each case at such other address as may hereafter be specified by any such Person to the other party in writing. All notices and communications shall be effective (i) if mailed, when received at the address
specified above, (ii) if facsimiled, when transmitted and (iii) if delivered, upon delivery. 
 THIS NOTE SHALL BE GOVERNED BY
AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. Each Borrower hereby consents to the service of process in any action or proceeding brought against it by the Lender by means of registered mail to the last known address to
such Borrower. Nothing herein, however, shall prevent service of process by any other means recognized as valid by law within or without the State of New York. EACH BORROWER HEREBY WAIVES AND AGREES TO WAIVE THE RIGHT TO TRIAL BY JURY IN ANY
ACTION, PROCEEDING, OR COUNTERCLAIM INSTITUTED WITH RESPECT TO ANY MATTER WHATSOEVER ARISING OUT OF OR IN ANY WAY CONNECTED TO THIS NOTE. By the execution of this Note, each Borrower hereby submits to the jurisdiction of courts located in the
County of New York, State of New York. 
 This Note may be executed in any number of counterparts, each of which shall be deemed an
original, and all of which taken together shall constitute but one agreement. 
  

  
 B-7 

 The Loans are payable “on demand”, but subject to the terms of Section 12 of
the Letter Agreement. 
 [SIGNATURE PAGE FOLLOWS] 

  
 B-8 

 
			
	BORROWER:
		
	By:	 	 
		 	Manish Desai, for each of the Borrowers listed on Schedule II hereto
	
	 Address: 333 South Grand Avenue, 28th Floor

                Los Angeles, CA 90071

  

			
	 ACCEPTED AND AGREED AS OF
 THE DATE
FIRST ABOVE WRITTEN:
  

	OAKTREE FUND GP I, L.P.
		
	By:	 	 
	 Name: Dan Levin
 Title:
  Authorized Signatory

  

			
		
	By:	 	 
	 Name: Jordan Mikes
 Title:
  Authorized Signatory

 [Master Note Signature Page] 

 SCHEDULE I TO MASTER NOTE 

 

											
	
Borrower
	  	
Date
	  	
Interest

Period
	  	
Principal
	  	
Interest
	  	
Unpaid
 Principal

Balance

of Note

	 	  	 	  	 	  	 	  	 	  	 

 Schedule I to Master Note 

 SCHEDULE II TO MASTER NOTE 

 

			
	
Borrower
	  	
Jurisdiction of Organization

	Oaktree Real Estate Income Trust, Inc.	  	Maryland

 Schedule II to Master Note 

 EXHIBIT C TO LETTER AGREEMENT 

CERTAIN DEFINED TERMS 
 As used in this Agreement,
the following terms have meanings specified below: 
 “Act” has the meaning given such term in Section 8(j) of this
Agreement. 
 “Agreement” means this Letter Agreement, together with the Exhibits hereto, as the same may be amended,
supplemented, or otherwise modified from time to time. 
 “Borrower” means each Person listed on Exhibit D hereto
(as such Exhibit may be updated from time to time by the Lender to reflect the addition of any new Persons as borrowers hereunder or termination of any Borrowers as borrowers hereunder). 

“Business Day” means any day on which commercial banks are not authorized or required to close in New York City. 

“Change of Control” means Oaktree Fund Advisors, LLC or an affiliate thereof shall not be acting in the capacity as
“Adviser” as set forth in the Advisory Agreement as contemplated by the Constituent Documents of the Borrower(s) or such “Adviser” shall cease to be directly or indirectly controlled by, or under common control with, Oaktree
Capital Management, L.P. 
 “Constituent Documents” means the constituent, governing, or organizational documents of a
Person, including (a) in the case of any limited partnership, exempted limited partnership, joint venture, trust or other form of business entity, the limited partnership, exempted limited partnership, joint venture or other applicable
agreement of formation of such Person and any agreement, statement, instrument, filing or notice with respect thereto filed in connection with its formation or registration with the secretary of state or registrar of exempted limited partnership or
other department in the jurisdiction of its formation; (b) in the case of any limited liability company, the articles of formation, the articles of association and operating agreement for such Person; and (c) in the case of a corporation
or exempted company, the certificate or articles of incorporation and the articles of association or bylaws for such Person; in each case, as the same may be amended, supplemented, or otherwise modified from time to time to the extent not prohibited
by this Agreement. 
 “Indemnitee” has the meaning given thereto in Section 5 of this Agreement. 

“Investments” means, in respect of any Borrower, direct or indirect investments permitted under the Constituent Documents of
such Borrower. 
 “Investor” means, in respect of any Borrower, any stockholders, limited partners or any other Persons who
subscribe to purchase the shares, limited partnership interests, limited liability company interests or other analogous equity interests in such Borrower. 

“Lender” means Oaktree Fund GP I, L.P. 

“Line” has the meaning given to such term in the first introductory paragraph of this Agreement. 

“Loan Documents” means, collectively, this Agreement, the Master Note and any other agreements or instruments made or entered
into by any Borrower with or in favor of the Lender in connection with this Agreement or the Master Note. 

  
 C-1 

 “Loan Request” has the meaning given thereto in Section 2(a) of this
Agreement. 
 “Loans” means, collectively, the loans made by the Lender to one or more Borrowers pursuant to this Agreement
and the applicable Master Note. 
 “Master Note” means the master promissory note in substantially the form of Exhibit
B to this Agreement executed and delivered by the Borrowers to the Lender under this Agreement, as the same may be amended, supplemented, or otherwise modified from time to time. 

“Obligations” means all obligations and liabilities of the Borrowers to the Lender in and under the Loan Documents, whether
matured or unmatured, absolute or contingent, now existing or hereafter incurred (including interest accruing after the commencement of any bankruptcy or insolvency proceeding, whether or not allowed or allowable thereunder). 

“Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company,
partnership, governmental authority or other entity. 
 * * * * * 

  
 C-2 

 EXHIBIT D TO LETTER AGREEMENT 

Borrowers: 

1.            Oaktree Real Estate Income Trust, Inc. 

  
 D-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]